In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.
Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD
Advertisement
Articles by Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD
Advertisement
Latest Updated Articles
- Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C
Published: May 3rd 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
5
